Optimizing PAS vs CBE-30 Filings to Reduce FDA Review Timelines in 2023 Optimizing PAS vs CBE-30 Filings to Reduce FDA Review Timelines in 2023 In the complex landscape of pharmaceutical regulation, understanding the nuances of post-approval submissions is crucial for speeding up FDA review timelines. This guide provides a comprehensive, step-by-step approach to effectively navigate the intricacies of Post-Approval Supplements (PAS) and Changes Being Effected (CBE-30) submissions. By following these structured steps, Regulatory Affairs professionals, Quality Assurance teams, and Lifecycle Management units can optimize their filing strategies to ensure timely approval and compliance with FDA regulations. Step 1: Understanding PAS…